Campbell & Co Investment Adviser’s Ingevity NGVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-6,269
Closed -$270K 1298
2025
Q2
$270K Sell
6,269
-643
-9% -$24.8K 0.02% 985
2025
Q1
$274K Buy
+6,912
New +$306K 0.02% 871
2024
Q1
Sell
-18,177
Closed -$858K 1289
2023
Q4
$858K Buy
+18,177
New +$755K 0.08% 454
2023
Q2
Sell
-3,906
Closed -$279K 1045
2023
Q1
$279K Sell
3,906
-311
-7% -$24.7K 0.05% 626
2022
Q4
$297K Buy
+4,217
New +$297K 0.07% 556
2022
Q1
Sell
-6,050
Closed -$434K 831
2021
Q4
$434K Buy
+6,050
New +$460K 0.15% 237

Other funds holding NGVT

Campbell & Co Investment Adviser's NGVT Position: Q3 2025 in Review

Campbell & Co Investment Adviser sold out of Ingevity (NGVT) in Q3 2025, closing a stake of 6,269 shares — an estimated $270K sold.

Campbell & Co Investment Adviser first reported a position in NGVT in Q4 2021 and held it in 6 quarters. The position peaked at $858K in Q4 2023. 298 funds tracked by Wall St. Rank hold NGVT as of Q3 2025.

  • Campbell & Co Investment Adviser reported no remaining Ingevity position as of Q3 2025 after selling out during the quarter.
  • Campbell & Co Investment Adviser sold 6,269 Ingevity shares in Q3 2025, an estimated $270K.
  • Campbell & Co Investment Adviser first reported a position in Ingevity in Q4 2021 and held it in 6 quarters.
  • Campbell & Co Investment Adviser's Ingevity position peaked at $858K in Q4 2023.
  • 298 funds tracked by Wall St. Rank held Ingevity as of Q3 2025.

Based on Campbell & Co Investment Adviser's 13F filing for Q3 2025, filed 28 Oct 2025.